Please login to the form below

Not currently logged in
Email:
Password:

GSK completes acquisition of Steifel

GSK has acquired the total share capital of Steifel Laboratories Inc in a cash deal worth $2.9bn

GlaxoSmithKline (GSK) has acquired the total share capital of Steifel Laboratories Inc in a cash deal worth $2.9bn.

As part of the deal, GSK has assumed $400m of net debt and may, dependent on the future performance of the business, be obliged to make additional cash payments of up to $300m.

GSK will operate its new dermatology business unit under the name Steifel, a GSK company.

Charles Stiefel, chairman of Stiefel, said: "As part of GSK, we are stronger, more competitive and continue to be a driving force in dermatology around the world. We are excited to combine GSK's prescription dermatology products, such as Bactroban, Cutivate and Altabax, with Stiefel's portfolio, including brands such as Duac, Olux E and Soriatane."

In 2008, Steifel products made approximately $900m in sales. This, combined with GSK's 2008 prescription dermatology product sales of $550m, creates pro forma revenues of around $1.5m – an 8 per cent share of the global prescription dermatology market.

22nd July 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics